Aflac Incorporated (NYSE:AFL – Get Free Report) major shareholder Post Holdings Co. Ltd. Japan sold 12,200 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $115.49, for a total transaction of $1,408,978.00. Following the sale, the insider owned 50,519,290 shares in the company, valued at $5,834,472,802.10. This represents a 0.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Post Holdings Co. Ltd. Japan also recently made the following trade(s):
- On Friday, September 18th, Post Holdings Co. Ltd. Japan sold 12,800 shares of Aflac stock. The stock was sold at an average price of $116.22, for a total transaction of $1,487,616.00.
- On Thursday, September 17th, Post Holdings Co. Ltd. Japan sold 12,900 shares of Aflac stock. The shares were sold at an average price of $116.58, for a total value of $1,503,882.00.
- On Wednesday, September 16th, Post Holdings Co. Ltd. Japan sold 13,800 shares of Aflac stock. The stock was sold at an average price of $117.49, for a total value of $1,621,362.00.
- On Monday, September 14th, Post Holdings Co. Ltd. Japan sold 13,600 shares of Aflac stock. The shares were sold at an average price of $116.74, for a total value of $1,587,664.00.
- On Friday, September 11th, Post Holdings Co. Ltd. Japan sold 14,000 shares of Aflac stock. The stock was sold at an average price of $115.14, for a total value of $1,611,960.00.
- On Thursday, September 10th, Post Holdings Co. Ltd. Japan sold 13,300 shares of Aflac stock. The shares were sold at an average price of $114.32, for a total value of $1,520,456.00.
- On Tuesday, September 8th, Post Holdings Co. Ltd. Japan sold 13,600 shares of Aflac stock. The stock was sold at an average price of $115.44, for a total transaction of $1,569,984.00.
- On Friday, September 4th, Post Holdings Co. Ltd. Japan sold 15,000 shares of Aflac stock. The shares were sold at an average price of $117.47, for a total transaction of $1,762,050.00.
- On Thursday, September 3rd, Post Holdings Co. Ltd. Japan sold 20,000 shares of Aflac stock. The shares were sold at an average price of $118.49, for a total transaction of $2,369,800.00.
- On Wednesday, September 2nd, Post Holdings Co. Ltd. Japan sold 13,500 shares of Aflac stock. The shares were sold at an average price of $117.19, for a total transaction of $1,582,065.00.
Aflac Stock Up 0.4%
Shares of NYSE:AFL traded up $0.43 during midday trading on Wednesday, hitting $115.03. 198,963 shares of the stock were exchanged, compared to its average volume of 2,328,460. The company has a market capitalization of $57.67 billion, a PE ratio of 12.34, a P/E/G ratio of 1.86 and a beta of 0.59. Aflac Incorporated has a 52-week low of $105.43 and a 52-week high of $130.22. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.12 and a current ratio of 0.12. The business’s fifty day simple moving average is $120.31 and its two-hundred day simple moving average is $116.51.
Aflac Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th were given a $0.61 dividend. This represents a $2.44 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, August 19th. Aflac’s payout ratio is currently 26.15%.
Key Headlines Impacting Aflac
Here are the key news stories impacting Aflac this week:
- Positive Sentiment: Aflac’s cancer-screening campaign with designer Rachel Zoe features a scannable, check-patterned jacket intended to encourage screenings. The initiative strengthens Aflac’s brand in cancer insurance and may support long-term customer engagement, although it is unlikely to materially affect near-term earnings. Aflac and Rachel Zoe cancer-screening campaign
- Neutral Sentiment: Aflac President Virgil Miller and former athlete Brian Jordan visited a children’s hospital to support families affected by cancer and sickle cell disease. The event may enhance corporate goodwill but has no clear immediate financial impact. Aflac hospital outreach event
- Neutral Sentiment: A life-insurance-sector recap continues to frame Aflac as a defensive, income-oriented insurer. Its valuation near 12 times earnings, 2.1% dividend yield and low beta may appeal to conservative investors, though the consensus analyst view remains “Hold.” Life-insurance stocks Q2 recap
- Negative Sentiment: Aflac’s latest quarterly results were mixed: adjusted earnings of $1.75 per share narrowly missed the $1.76 consensus estimate, while revenue of $4.22 billion exceeded expectations but declined 1% year over year. The earnings miss and lower revenue trend have weighed on investor sentiment. Aflac earnings miss and revenue beat
- Negative Sentiment: Japan Post Holdings sold another 12,800 Aflac shares for approximately $1.49 million, following several similar sales during September. The transaction reduced its ownership by only 0.03% and was conducted under a pre-arranged Rule 10b5-1 plan, limiting its fundamental significance but creating a modest supply overhang. SEC filing on Japan Post Holdings sale
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on AFL shares. Wells Fargo & Company set a $122.00 price objective on shares of Aflac and gave the stock an “equal weight” rating in a report on Wednesday, August 19th. Barclays reissued an “underweight” rating and issued a $99.00 price objective (up from $98.00) on shares of Aflac in a research note on Friday, August 7th. JPMorgan Chase & Co. reduced their target price on Aflac from $117.00 to $116.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Jefferies Financial Group reiterated a “hold” rating and set a $108.00 price target (up from $100.00) on shares of Aflac in a report on Friday, July 10th. Finally, TD Cowen reissued a “hold” rating and issued a $110.00 price target (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $116.62.
Check Out Our Latest Analysis on Aflac
Institutional Trading of Aflac
Hedge funds have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in shares of Aflac during the 2nd quarter worth about $4,093,787,000. Norges Bank acquired a new position in Aflac in the 4th quarter valued at approximately $420,078,000. Legal & General Group Plc bought a new stake in shares of Aflac in the 2nd quarter worth approximately $404,639,000. Bank of New York Mellon Corp acquired a new stake in shares of Aflac during the 2nd quarter worth approximately $298,418,000. Finally, Bank of America Corp DE bought a new stake in shares of Aflac during the second quarter valued at approximately $244,516,000. 67.44% of the stock is owned by institutional investors.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance products. Its coverage is designed to help policyholders manage expenses that may not be fully covered by major medical insurance, including costs associated with accidents, illness, hospitalization, disability and critical illness.
Through its U.S. operations, Aflac markets policies to individuals, businesses and employees through workplace benefit programs, independent agents and brokers. The company is also a major provider of supplemental insurance in Japan, where it offers products focused primarily on cancer, medical and income-support coverage.
Founded in 1955 in Columbus, Georgia, as American Family Life Assurance Company, the business adopted the name Aflac in 1990.
Further Reading
- Five stocks we like better than Aflac
- Sandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?
- These 4 Companies Are Monetizing AI Today
- Quantum and Rare Earths? Implications of the Pasqal/USAR Partnership
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
